nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0528	0.0616	CbGbCtD
Pyrimethamine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0528	0.0616	CbGbCtD
Pyrimethamine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0433	0.0505	CbGbCtD
Pyrimethamine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0407	0.0475	CbGbCtD
Pyrimethamine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0407	0.0475	CbGbCtD
Pyrimethamine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.04	0.0467	CbGbCtD
Pyrimethamine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.04	0.0467	CbGbCtD
Pyrimethamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0396	0.0462	CbGbCtD
Pyrimethamine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0384	0.0447	CbGbCtD
Pyrimethamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0373	0.0434	CbGbCtD
Pyrimethamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0373	0.0434	CbGbCtD
Pyrimethamine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0368	0.043	CbGbCtD
Pyrimethamine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0368	0.043	CbGbCtD
Pyrimethamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0337	0.0393	CbGbCtD
Pyrimethamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0337	0.0393	CbGbCtD
Pyrimethamine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0318	0.0371	CbGbCtD
Pyrimethamine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0309	0.036	CbGbCtD
Pyrimethamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0291	0.0339	CbGbCtD
Pyrimethamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0282	0.0329	CbGbCtD
Pyrimethamine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0279	0.0326	CbGbCtD
Pyrimethamine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0279	0.0326	CbGbCtD
Pyrimethamine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0268	0.0312	CbGbCtD
Pyrimethamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0255	0.0298	CbGbCtD
Pyrimethamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0255	0.0298	CbGbCtD
Pyrimethamine—Stevens-Johnson syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00221	0.0184	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Nevirapine—acquired immunodeficiency syndrome	0.00213	0.0178	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Abacavir—acquired immunodeficiency syndrome	0.00203	0.017	CcSEcCtD
Pyrimethamine—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.00189	0.0158	CcSEcCtD
Pyrimethamine—DHFR—retina—acquired immunodeficiency syndrome	0.00186	0.0822	CbGeAlD
Pyrimethamine—Stevens-Johnson syndrome—Nevirapine—acquired immunodeficiency syndrome	0.00181	0.0151	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.015	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Abacavir—acquired immunodeficiency syndrome	0.00172	0.0144	CcSEcCtD
Pyrimethamine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00168	0.0745	CbGeAlD
Pyrimethamine—Haematuria—Stavudine—acquired immunodeficiency syndrome	0.00168	0.014	CcSEcCtD
Pyrimethamine—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.0136	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.0131	CcSEcCtD
Pyrimethamine—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.00155	0.0129	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.0127	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.0126	CcSEcCtD
Pyrimethamine—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.0015	0.0125	CcSEcCtD
Pyrimethamine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.0015	0.0662	CbGeAlD
Pyrimethamine—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.00147	0.0123	CcSEcCtD
Pyrimethamine—Haematuria—Zidovudine—acquired immunodeficiency syndrome	0.00146	0.0122	CcSEcCtD
Pyrimethamine—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.012	CcSEcCtD
Pyrimethamine—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00142	0.0119	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Indinavir—acquired immunodeficiency syndrome	0.00141	0.0118	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.0116	CcSEcCtD
Pyrimethamine—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.0115	CcSEcCtD
Pyrimethamine—Haematuria—Indinavir—acquired immunodeficiency syndrome	0.00136	0.0114	CcSEcCtD
Pyrimethamine—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.00135	0.0113	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.0112	CcSEcCtD
Pyrimethamine—DHFR—lymphoid tissue—acquired immunodeficiency syndrome	0.00132	0.0584	CbGeAlD
Pyrimethamine—DHFR—digestive system—acquired immunodeficiency syndrome	0.0013	0.0577	CbGeAlD
Pyrimethamine—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.0013	0.0109	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00129	0.0108	CcSEcCtD
Pyrimethamine—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.0107	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.0107	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00127	0.0106	CcSEcCtD
Pyrimethamine—DHFR—blood—acquired immunodeficiency syndrome	0.00124	0.055	CbGeAlD
Pyrimethamine—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.0103	CcSEcCtD
Pyrimethamine—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00123	0.0103	CcSEcCtD
Pyrimethamine—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00123	0.0103	CcSEcCtD
Pyrimethamine—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00123	0.0103	CcSEcCtD
Pyrimethamine—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.00123	0.0103	CcSEcCtD
Pyrimethamine—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.0102	CcSEcCtD
Pyrimethamine—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00121	0.0101	CcSEcCtD
Pyrimethamine—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.00121	0.0101	CcSEcCtD
Pyrimethamine—DHFR—bone marrow—acquired immunodeficiency syndrome	0.0012	0.0532	CbGeAlD
Pyrimethamine—DHFR—spinal cord—acquired immunodeficiency syndrome	0.0012	0.0529	CbGeAlD
Pyrimethamine—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00973	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00116	0.00973	CcSEcCtD
Pyrimethamine—DHFR—vagina—acquired immunodeficiency syndrome	0.00115	0.0509	CbGeAlD
Pyrimethamine—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00955	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00114	0.00953	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.0095	CcSEcCtD
Pyrimethamine—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00949	CcSEcCtD
Pyrimethamine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.00112	0.00941	CcSEcCtD
Pyrimethamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0496	CbGeAlD
Pyrimethamine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.00111	0.00927	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00925	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00922	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.0011	0.0092	CcSEcCtD
Pyrimethamine—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00913	CcSEcCtD
Pyrimethamine—DHFR—lung—acquired immunodeficiency syndrome	0.00109	0.0482	CbGeAlD
Pyrimethamine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00906	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00906	CcSEcCtD
Pyrimethamine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.00107	0.00898	CcSEcCtD
Pyrimethamine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00895	CcSEcCtD
Pyrimethamine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.00107	0.00895	CcSEcCtD
Pyrimethamine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00106	0.00882	CcSEcCtD
Pyrimethamine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00101	0.00846	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00845	CcSEcCtD
Pyrimethamine—DHFR—nervous system—acquired immunodeficiency syndrome	0.00101	0.0446	CbGeAlD
Pyrimethamine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00098	0.00819	CcSEcCtD
Pyrimethamine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000977	0.00817	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000977	0.00816	CcSEcCtD
Pyrimethamine—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000972	0.00813	CcSEcCtD
Pyrimethamine—DHFR—central nervous system—acquired immunodeficiency syndrome	0.000971	0.043	CbGeAlD
Pyrimethamine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000962	0.00804	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000956	0.00799	CcSEcCtD
Pyrimethamine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000953	0.00797	CcSEcCtD
Pyrimethamine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000931	0.00778	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000928	0.00776	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000908	0.00759	CcSEcCtD
Pyrimethamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000903	0.00755	CcSEcCtD
Pyrimethamine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.0009	0.00753	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000889	0.00743	CcSEcCtD
Pyrimethamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000866	0.00724	CcSEcCtD
Pyrimethamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000857	0.00717	CcSEcCtD
Pyrimethamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000849	0.0071	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00084	0.00702	CcSEcCtD
Pyrimethamine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000833	0.00696	CcSEcCtD
Pyrimethamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00083	0.00694	CcSEcCtD
Pyrimethamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000828	0.00692	CcSEcCtD
Pyrimethamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000823	0.00688	CcSEcCtD
Pyrimethamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000818	0.00684	CcSEcCtD
Pyrimethamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000815	0.00682	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000804	0.00672	CcSEcCtD
Pyrimethamine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000801	0.0067	CcSEcCtD
Pyrimethamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000789	0.0066	CcSEcCtD
Pyrimethamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000783	0.00654	CcSEcCtD
Pyrimethamine—DHFR—brain—acquired immunodeficiency syndrome	0.000771	0.0341	CbGeAlD
Pyrimethamine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000765	0.00639	CcSEcCtD
Pyrimethamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000746	0.00624	CcSEcCtD
Pyrimethamine—DHFR—lymph node—acquired immunodeficiency syndrome	0.000745	0.0329	CbGeAlD
Pyrimethamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000743	0.00621	CcSEcCtD
Pyrimethamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00074	0.00619	CcSEcCtD
Pyrimethamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000724	0.00605	CcSEcCtD
Pyrimethamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000717	0.00599	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000715	0.00598	CcSEcCtD
Pyrimethamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000714	0.00597	CcSEcCtD
Pyrimethamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000714	0.00597	CcSEcCtD
Pyrimethamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000704	0.00588	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000697	0.00583	CcSEcCtD
Pyrimethamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000697	0.00582	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.00571	CcSEcCtD
Pyrimethamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000669	0.00559	CcSEcCtD
Pyrimethamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000664	0.00556	CcSEcCtD
Pyrimethamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00066	0.00552	CcSEcCtD
Pyrimethamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000635	0.00531	CcSEcCtD
Pyrimethamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000632	0.00529	CcSEcCtD
Pyrimethamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000621	0.00519	CcSEcCtD
Pyrimethamine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000617	0.0273	CbGeAlD
Pyrimethamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000606	0.00507	CcSEcCtD
Pyrimethamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000605	0.00506	CcSEcCtD
Pyrimethamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000577	0.00483	CcSEcCtD
Pyrimethamine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000575	0.0254	CbGeAlD
Pyrimethamine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000572	0.0253	CbGeAlD
Pyrimethamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000559	0.00468	CcSEcCtD
Pyrimethamine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000548	0.0242	CbGeAlD
Pyrimethamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000546	0.00456	CcSEcCtD
Pyrimethamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000538	0.0045	CcSEcCtD
Pyrimethamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000522	0.00436	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000514	0.00429	CcSEcCtD
Pyrimethamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000483	0.00404	CcSEcCtD
Pyrimethamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000465	0.00388	CcSEcCtD
Pyrimethamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000443	0.00371	CcSEcCtD
Pyrimethamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000432	0.0191	CbGeAlD
Pyrimethamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000411	0.0182	CbGeAlD
Pyrimethamine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000383	0.0169	CbGeAlD
Pyrimethamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000334	0.0148	CbGeAlD
Pyrimethamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000321	0.0142	CbGeAlD
Pyrimethamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000255	0.0113	CbGeAlD
